Alzheimer disease trials in France

In France 85 Also abroad 816

85 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.

Phase 2RecruitingTrial-stage medicine
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Where
Bron, Lille Cedex, Montpellier Cedex 5, Paris, Toulouse
Age
50 years to 90 years
People
450 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07781657EU 2026-526158-14-00Registry updated 2026-11-06
Phase 2/3RecruitingTrial-stage medicine
ACP-204 in Adults With Alzheimer's Disease Psychosis
Where
Bron, Colmar Cedex, Dijon, Limoges, Paris, Paris Cedex 10, Rouen, Toulouse, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Villeurbanne
Age
55 years to 95 years
People
1,074 worldwide
Run by
ACADIA Pharmaceuticals Inc.
See details and how to joinNCT06159673EU 2023-507325-42-00Registry updated 2026-11-05
No phaseRecruitingResearch participation
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pilot Study
Where
Tours
Age
18 years and over
People
90
Run by
University Hospital, Tours
See details and how to joinNCT06661564Registry updated 2026-11-05
Phase 3Enrolling by invitationTrial-stage medicine
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
Where
Bron, Colmar Cedex, Dijon, Limoges, Paris, Paris Cedex 10, Rouen, Toulouse, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Villeurbanne
Age
55 years to 95 years
People
752 worldwide
Run by
ACADIA Pharmaceuticals Inc.
See details and how to joinNCT06194799EU 2023-507351-29-00Registry updated 2026-11-04
Phase 3RecruitingTrial-stage medicine
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Where
Lille Cedex, Limoges Cedex 1, Montpellier Cedex 5, Paris, Strasbourg, Toulouse Cedex 9, Villeurbanne
Age
55 years to 90 years
People
426 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07011745EU 2025-520612-34-00Registry updated 2026-11-03
No phaseRecruitingResearch participation
OCT-Angiography and Adaptive Optics in Patients With Memory Impairment
Where
Paris
Age
18 years and over
People
450
Run by
Fondation Ophtalmologique Adolphe de Rothschild
See details and how to joinNCT04389437Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Nice, Toulouse, Tours
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787EU 2024-516363-92-00Registry updated 2026-10-27
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Where
Dijon, Montpellier Cedex 5, Nice, Reims Cedex, Rouen Cedex, Toulouse, Villeurbanne
Age
60 years to 85 years
People
586 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06976216EU 2025-520746-30-00Registry updated 2026-10-27
Phase 3RecruitingTrial-stage medicine
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Where
Nice, Reims Cedex, Rouen Cedex, Toulouse, Tours
Age
55 years to 90 years
People
1,000 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT05980949EU 2023-504151-27-00Registry updated 2026-10-16
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Where
Lille Cedex, Limoges, Montpellier Cedex 5, Paris, Strasbourg, Toulouse Cedex 9, Villeurbanne
Age
55 years to 90 years
People
650 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06937229EU 2024-519994-20-00Registry updated 2026-10-16
Phase 2/3RecruitingResearch participation
A Study of Treatments for the Prevention of Disease Progression in Individuals at Risk for or With Early Onset Alzheimer’s Disease Caused by a Genetic Mutation
Where
Bron, Lille Cedex, Paris Cedex 13, Rouen Cedex, Toulouse
Age
18 years and over
People
27 worldwide
Run by
Washington University School Of Medicine
See details and how to join2024-517187-36-01EU 2024-517187-36-01Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Where
Bordeaux, Bron, Lille Cedex, Marseille, Nancy, Paris, Rennes Cedex 9, Saint-Herblain, Strasbourg, Toulouse Cedex 9, Tours
Age
60 years to 85 years
People
586 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06976203EU 2025-520747-32-00Registry updated 2026-10-08
Phase 2RecruitingTrial-stage medicine
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Where
Strasbourg, Toulouse Cedex 9
Age
55 years to 90 years
People
300 worldwide
Run by
MapLight Therapeutics
See details and how to joinNCT06887192EU 2024-519820-26-00Registry updated 2026-09-30
No phaseRecruitingResearch participation
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
Where
Dijon
Age
18 years and over
People
74
Run by
Centre Hospitalier Universitaire Dijon
See details and how to joinNCT05888961Registry updated 2026-09-25
No phaseRecruitingResearch participation
Study of Repetitive Behaviors in Alzheimer's Disease
Where
Limoges
Age
18 years and over
People
103
Run by
Centre Hospitalier Esquirol
See details and how to joinNCT07732842Registry updated 2026-09-10
No phaseRecruitingResearch participation
ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness
Where
Huningue
Age
45 years and over
People
50,000
Run by
Firalis SA
See details and how to joinNCT07679906Registry updated 2026-09-02
No phaseRecruitingResearch participation
Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease
Where
Castres, Lavaur, Paris, Saint-Herblain, Toulouse, Villeurbanne
Age
55 years to 85 years
People
108
Run by
REGEnLIFE SAS
See details and how to joinNCT05926011Registry updated 2026-08-21
Phase 2/3RecruitingResearch participation
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
Where
ORSAY, Paris Cedex 13
Age
40 years to 80 years
People
45
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT04150198EU 2024-519995-20-00Registry updated 2026-08-20
Phase 3RecruitingTrial-stage medicine
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Where
Dijon, Reims, Rouen, Villeurbanne
Age
55 years to 90 years
People
410 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT05511363Registry updated 2026-08-17
Phase 2Enrolling by invitationTrial-stage medicine
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Where
Strasbourg, Toulouse
Age
55 years to 91 years
People
210 worldwide
Run by
MapLight Therapeutics
See details and how to joinNCT07459660EU 2025-521757-16-00Registry updated 2026-08-07
No phaseRecruitingResearch participation
Effects of Musical Intervention by a Therapist (IMT) on Falling Asleep and Behavioral Regulation in a Secure Care Unit (SCU)
Where
Saint-Etienne
Age
60 years and over
People
48
Run by
Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT07465783Registry updated 2026-08-03
No phaseRecruitingResearch participation
Validation of a Remediation Method for Memory Impairments Through Motor Encoding in Patients With Alzheimer's Disease
Where
Grenoble, Saint-Etienne, Villeurbanne
Age
60 years and over
People
80
Run by
Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT07632755Registry updated 2026-07-31
Phase 2/3RecruitingTrial-stage medicine
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Where
Bron, Lille, Paris, Rouen, Toulouse
Age
18 years and over
People
280 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT05552157Registry updated 2026-07-27
Phase 2/3RecruitingTrial-stage medicine
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Where
Bron, Lille, Paris, Rouen, Toulouse
Age
18 years and over
People
280 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT06647498Registry updated 2026-07-27
Phase 2RecruitingResearch participation
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
Where
Toulouse
Age
60 years to 100 years
People
100
Run by
University Hospital, Toulouse
See details and how to joinNCT07007208EU 2023-507668-38-00Registry updated 2026-07-17

All Alzheimer disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error